Vein graft failure after coronary artery bypass graft surgery was associated with an increased risk of death, myocardial infarction, or revascularization (HR 1.58; 95% CI 1.21-2.06; P=0.008).
Cohort (n=1,829)
Does vein graft failure after CABG surgery increase the risk of death, myocardial infarction, or repeat revascularization?
Vein graft failure 12-18 months after CABG is associated with an increased risk of subsequent repeat revascularization, but not death or myocardial infarction.
Effect estimate: HR 1.58 (95% CI 1.21-2.06)
p-value: p=0.008
BACKGROUND: Vein graft failure (VGF) is common after coronary artery bypass graft surgery, but its relationship with long-term clinical outcomes is unknown. In this retrospective analysis, we examined the relationship between VGF, assessed by coronary angiography 12 to 18 months after coronary artery bypass graft surgery, and subsequent clinical outcomes. METHODS AND RESULTS: Using the Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) trial database, we studied data from 1829 patients who underwent coronary artery bypass graft surgery and had an angiogram performed up to 18 months after surgery. The main outcome measure was death, myocardial infarction, and repeat revascularization through 4 years after angiography. VGF occurred in 787 of 1829 patients (43%). Clinical follow-up was completed in 97% of patients with angiographic follow-up. The composite of death, myocardial infarction, or revascularization occurred more frequently among patients who had any VGF compared with those who had none (adjusted hazard ratio, 1.58; 95% confidence interval, 1.21-2.06; P=0.008). This was due mainly to more frequent revascularization with no differences in death (adjusted hazard ratio, 1.04; 95% confidence interval, 0.71-1.52; P=0.85) or death or myocardial infarction (adjusted hazard ratio, 1.08; 95% confidence interval, 0.77-1.53; P=0.65). CONCLUSIONS: VGF is common after coronary artery bypass graft surgery and is associated with repeat revascularization but not with death and/or myocardial infarction. Further investigations are needed to evaluate therapies and strategies for decreasing VGF to improve outcomes in patients undergoing coronary artery bypass graft surgery.
Lópes et al. (Thu,) conducted a cohort in Coronary artery bypass graft surgery (n=1,829). Vein graft failure vs. No vein graft failure was evaluated on Composite of death, myocardial infarction, and repeat revascularization (HR 1.58, 95% CI 1.21-2.06, p=0.008). Vein graft failure after coronary artery bypass graft surgery was associated with an increased risk of death, myocardial infarction, or revascularization (HR 1.58; 95% CI 1.21-2.06; P=0.008).